Our work here has further enriched the knowledge of the molecular pathways governing renal MCC development by identifying Cnr1 as a critical regulator for renal MCC development through the use of genetically deficient models and pharmacological approaches. This evidence concerns the gene CNR1 and Merkel cell skin cancer.